New drug 'functionally cures' many hepatitis B virus infections
gmays
128 points
20 comments
June 08, 2026
Related Discussions
Found 5 related stories in 204.4ms across 15,062 title embeddings via pgvector HNSW
- Experimental drug reverses fatty liver disease by repairing the gut brandonb · 12 pts · July 12, 2026 · 57% similar
- Alzheimer's patient gets back speech, bladder control and memory in drug trial virgildotcodes · 20 pts · June 06, 2026 · 45% similar
- New iron nanomaterial wipes out cancer cells without harming healthy tissue gradus_ad · 274 pts · March 01, 2026 · 45% similar
- A revolutionary cancer treatment could transform autoimmune disease 0in · 32 pts · May 17, 2026 · 43% similar
- New Drugs for Pancreatic Cancer Show Remarkable Promise for Deadly Disease megacorp · 11 pts · April 22, 2026 · 42% similar
Discussion Highlights (5 comments)
TZubiri
Are treated patients still contagious? If so, if a treated patient spreads the virus, will that new patient carry an innoculated virus? Or will they suffer a standard infection?
madanparas
The trial enrolled non-cirrhotic patients with moderate baseline HBsAg (100 to 3,000 IU/mL) already on stable nucleotide analogue therapy. That selection matters because HBV-related deaths are driven almost entirely by cirrhosis and hepatocellular carcinoma, and those outcomes cluster in patients with higher antigen loads and advanced disease. The 19% result is real and independently replicated in over 1,800 patients, but whether bepirovirsen reduces the 1.1 million HBV deaths per year depends on trials in populations that weren't enrolled here.
amwet
Pretty sure the cover image is a Strokes album cover.
halapro
I'm surprised that they're working on HB cures since there's been an HB vaccine for 40 years. I'd love to see more work done towards other incurable viruses like HSV (no vaccine) and HPV (limited vaccine)
GreenSalem
Indian pharmaceutical companies will produce a biosimilar in months. This will enable it to be supplied at a non-exploitative price to Africa and Asia.